EUVIMEDOpdag EUVIMED
Crossref

Dual Ionizable Lipids (ALC0315 and SM102) in a Novel Lipid Nanoparticle Formulation Enhance In Vivo Delivery and Time‐Dependent Expression of Messenger RNA and Self‐Amplifying RNA

Dmitry Kunyk, Olga Vasileva, Mikhail Bespalov, Alina Dzharullaeva, Elena Mazunina, Anastasia Chubarova, Maxim Seliverstov, Denis Smirnykh, Daniil Shevyrev, Sofia Shtraus, Alena Kozlova, Elena Subcheva and 8 more

ChemMedChem · 2026-06-15 · 21 (11)

DOI: 10.1002/cmdc.70335 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-06-09. Written by Dmitry Kunyk and 19 co-authors. Institution: Translational Medicine Research Center, Sirius University of Science and Technology, Sochi, Russia. Major MEDLINE topics: Nanoparticles, RNA, Messenger, Lipids. Cited 2 times so far (Crossref); 46 references. Funded by: "Sirius" Federal Territory "Scientific and technological development of the "Sirius" Federal Territory".

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This study introduces a novel five‐component LNP formulation incorporating ionizable lipid combination ALC‐0315 and SM‐102 with cholesterol, DSPC, and DMG‐PEG‐2000. LNP‐5 was designed for efficient delivery of mRNA and saRNA. We employed a Design of Experiments approach and microfluidics to optimize the formulation parameters, achieving high encapsulation efficiencies (>80%) for both RNA types. Physicochemical characterization by dynamic light scattering confirmed a controlled size (80–120 nm) and low polydispersity (

Subjects

MeSH terms (MEDLINE)

NanoparticlesRNA, MessengerLipidsAnimalsParticle SizeHumansMiceLiposomes

Author keywords

SM‐102 and ALC‐0315in vivolipid nanoparticlesmRNAsaRNA

Substances

RNA, MessengerLipidsLipid NanoparticlesLiposomes

Authors and institutions

  • Translational Medicine Research Center, Sirius University of Science and Technology, Sochi, Russia.
  • Federal State Budget Institution "National Research Centre for Epidemiology and Microbiology Named After Honorary Academician N. F. Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Sechenov First Moscow State Medical University, Moscow, Russia.

ORCID profiles: Roman Ivanov, Ivan A Skvortsov

Funding

  • "Sirius" Federal Territory "Scientific and technological development of the "Sirius" Federal Territory"

Cite

APA

Kunyk, D., Vasileva, O., Bespalov, M., Dzharullaeva, A., Mazunina, E., Chubarova, A., Seliverstov, M., Smirnykh, D., Shevyrev, D., Shtraus, S., Kozlova, A., Subcheva, E., Kleymenov, D., Bykonia, E., Baranov, M. V., Logunov, D. Y., Gushchin, V. А., Ivanov, R., Reshetnikov, V., & Skvortsov, I. A. (2026). Dual Ionizable Lipids (ALC0315 and SM102) in a Novel Lipid Nanoparticle Formulation Enhance In Vivo Delivery and Time‐Dependent Expression of Messenger RNA and Self‐Amplifying RNA. ChemMedChem, 21(11). https://doi.org/10.1002/cmdc.70335

Vancouver

Kunyk D, Vasileva O, Bespalov M, Dzharullaeva A, Mazunina E, Chubarova A, et al. Dual Ionizable Lipids (ALC0315 and SM102) in a Novel Lipid Nanoparticle Formulation Enhance In Vivo Delivery and Time‐Dependent Expression of Messenger RNA and Self‐Amplifying RNA. ChemMedChem. 2026;21(11). doi:10.1002/cmdc.70335

BibTeX
@article{Kunyk2026,
  author = {Kunyk, Dmitry and Vasileva, Olga and Bespalov, Mikhail and Dzharullaeva, Alina and Mazunina, Elena and Chubarova, Anastasia and Seliverstov, Maxim and Smirnykh, Denis and Shevyrev, Daniil and Shtraus, Sofia and Kozlova, Alena and Subcheva, Elena and Kleymenov, Denis and Bykonia, Evgeniia and Baranov, Maxim V and Logunov, Denis Y and Gushchin, Vladimir А and Ivanov, Roman and Reshetnikov, Vasiliy and Skvortsov, Ivan A},
  title = {Dual Ionizable Lipids (ALC0315 and SM102) in a Novel Lipid Nanoparticle Formulation Enhance In Vivo Delivery and Time‐Dependent Expression of Messenger RNA and Self‐Amplifying RNA},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {11},
  doi = {10.1002/cmdc.70335}
}
Start for free →